Palatin prices $15.8 million public offering, regains NYSE American listing compliance
Palatin Technologies agreed on November 5, 2025 to sell 2,430,769 shares (or pre-funded warrants) at $6.50 per share, together with Series J and Series K warrants, with gross proceeds expected to be about $15.8 million. The company said the closing should restore compliance with the NYSE American stockholders' equity rule, and its common stock is expected to resume trading under PTN on November 12, 2025, but the new shares and warrants add potential dilution for existing holders.
Key points
- Offering of 2,430,769 shares or pre-funded warrants at $6.50 per share, with Series J and Series K warrants, for expected gross proceeds of about $15.8 million
- Series J warrants have a $6.50 exercise price; Series K warrants have an $8.125 exercise price and are tied to an FDA acceptance of an obesity compound IND
- Closing is expected on or about November 12, 2025, the same day trading is expected to resume on NYSE American under PTN
- Expected net proceeds of $14.7 million; up to an additional $15.8 million could come from Series J warrant exercises, which is not guaranteed
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.